Earnings Preview — 5191 total
Dorman Products reports Q1 results today with options traders positioned more bullishly than at any point in recent months. The clearest signal is the put/call ratio. It has fallen to 0.55, well below its 20-day…
Lifetime Brands reports Q1 results on May 7 with the stock reeling from a sharp pullback and short sellers building positions fast. The price story alone sets a charged backdrop. LCUT fell 11% on Monday alone,…
FreightCar America reports Q1 results today against a backdrop of a sudden and sharp spike in borrowing costs — the most striking signal in an otherwise quiet positioning picture. The cost to borrow shares jumped…
CYRX reports Q1 2026 results tomorrow with the options market signalling unusually strong bullish conviction — the kind rarely seen in a small-cap life sciences name. The clearest positioning signal is the put/call…
MAERSK B arrives at its May 7 Q1 earnings release as one of the most heavily shorted large-cap shipping stocks in Europe — and with geopolitical headline risk now sitting directly on the front page. Short sellers have…
Piper Sandler heads into its May 7 earnings release with its stock under pressure but short sellers quietly retreating — a divergence that shapes the entire setup. The stock fell 2.2% on Monday to $77.67, capping a…
WYNN reports Q1 results on May 6 with short sellers at their most committed position in months — a steady build that has yet to reverse heading into the print. Short interest has climbed to 11.3% of free float, up from…
GEF heads into its May 6 Q2 earnings release with options traders notably more defensive than they have been all quarter. The put/call ratio has jumped to 0.61, well above its 20-day average of 0.36 — nearly 1.4…
Vornado Realty Trust heads into its Q1 2026 earnings report today with a striking split: a board member buying aggressively on the way down while the analyst community has spent six weeks cutting targets. The insider…
Universal Display Corporation heads into its May 7 earnings report with analysts methodically cutting price targets while the stock has quietly recovered ground — a tension that frames the entire setup. The most…
Unitil Corporation reports Q1 2026 results today against a backdrop of easing short pressure and a lending market that shows little sign of stress. Short sellers have been pulling back. At 3.1% of the free float, short…
UFP Technologies heads into its Q1 2026 report on May 5 as one of the more heavily shorted names in the health care supplies space — and shorts have been rebuilding quietly over recent weeks. Short sellers have been…
Tennant Company heads into its May 5 Q1 2026 earnings print with short sellers adding positions at the fastest pace in months — even as the stock has staged a sharp recovery. The short-side buildup is the clearest…
STRL reports Q1 results today against an unusually bullish backdrop — a stock up 27% in a month, fresh analyst initiations, and a CEO who has been selling hard. Options positioning has eased heading into the print. The…
Diversified Healthcare Trust heads into its Q1 2026 earnings report today with options traders leaning unusually bullish — a notable contrast to the cautious positioning more typical ahead of REIT earnings. Options…
Sangamo Therapeutics approaches its May 7 earnings release with short sellers firmly in control of the tape — and a stock that has lost 41% in a month to trade at $0.18. Short interest tells the dominant story into…
RioCan Real Estate Investment Trust reports its Q1 2026 results today with a rare tailwind: the stock has climbed 10% over the past month and is running up 14% year-to-date to CAD 21.68, well ahead of most peers in the…
Powell Industries heads into its Q2 FY2026 results today carrying one of the more charged short setups in the mid-cap industrials space. Short interest is high but retreating fast. At 27.6% of the free float, the short…
Otter Tail Corporation heads into its Q1 2026 earnings print today with short sellers holding an unusually large position — yet the borrow market shows no sign of stress. Short interest is the standout heading into…
Oncolytics Biotech heads into its May 8 earnings report with the most compelling signal coming not from the options desk, but from the boardroom. Ten insiders bought shares on or around February 12 — including the CEO,…
